Science and Research

The ubiquitin proteasome system as a potential therapeutic target for systemic sclerosis

The present review aims to summarize available knowledge on the role of the ubiquitin-proteasome system (UPS) in the pathogenesis of scleroderma and scleroderma-related disease mechanisms. This will provide the reader with a more mechanistic understanding of disease pathogenesis and help to identify putative novel targets within the UPS for potential therapeutic intervention. Because of the heterogenous manifestations of scleroderma, we will primarily focus on conserved mechanisms that are involved in the development of lung scleroderma phenotypes.

  • Meiners, S.
  • Evankovich, J.
  • Mallampalli, R. K.
Publication details
DOI: 10.1016/j.trsl.2018.03.003
Journal: Translational research : the journal of laboratory and clinical medicine
Pages: 17-28 
Work Type: Review
Location: CPC-M
Disease Area: COPD
Partner / Member: LMU
Access-Number: 29702079
See publication on PubMed

DZL Engagements

chevron-down